Multiplex Assays Market Share

Multiplex Assays Market Overview

The multiplex assays market size is expected to reach USD 3.70 Billion by 2032 at CAGR of 7.1% during the forecast period (2023-2032). An assay which simultaneously measures multiple analysts in a single cycle is known as a multiplex assay. Technological advancement is one of the driving factors for the growth of this market. The rapid development in nanotechnology has taken this to the next level of nanoarray, which represents the ultra-miniaturization version of the conventional microarray. Increasing awareness about the multifactorial nature of various diseases and pathological conditions such as cancer and Alzheimer disease has created a requirement to produce a cost-effective and time-saving measurement of multiple analysts in a single sample. This factor drives the multiplex assays market.

Reproducibility crisis and complex clinical trial procedures for multiplex assay products are limiting the growth of the market.

Multiplex Assays Market Segment Insights

The multiplex assays market is segmented on the basis of products and services, types, technology, application, and end-user. On the basis of products and services, the multiplex assays market is segmented into consumable, instrument, and software and services. 

Multiplex Assays Types Insights

Based on types, the market is segmented into protein, nucleic acid, and cell-based multiplex assay. Further, protein multiplex assay is sub-segmented into planer protein assay and bead-based protein assay. Nucleic acid multiplex assay is further sub-segmented into planer nucleic acid assay, bead-based nucleic acid assay, and other nucleic acid assay. 

Multiplex Assays Technology Insights

On the basis of technology, the multiplex assay market is further segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, and other technologies. 

Multiplex Assays Application Insights

Further on the basis of application, the market is segmented into research and development, clinical diagnostic, and other diseases. Research and development is further sub-segmented into drug discovery and development, biomarker discovery, and validation. Clinical diagnostic is further sub-segmented into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, and other diseases. 

Multiplex Assays End User Insights

Based on end-user, the market is segmented into pharmaceutical and biotechnology companies, hospital and research institutes, clinical laboratories, and other end-users.

Competitors Analysis

Some of the key players in the multiplex assays market are 

• Thermo Fisher Scientific Inc, 


• Bio Rad Laboratories Inc, 


• Qiagen, 


• Abcam plc, 


• BD, 


• Merck Sharp & Dohme Corp, 


• Agilent Technologies, 


• Illumina Inc, 


• Meso Scale Diagnostics LLC, 


• Randox Laboratories Ltd,  


• Quanterix, 


• Bio-Techne, and  


• Seegene Inc.

Regional Market Summary

The multiplex assays market is divided into four major regions, namely, North America, Europe, Asia-Pacific, and the rest of the world. North America accounts for the largest share of the multiplex assays market owing to strong R&D activities in this region. The US is a leading country in biopharmaceutical research and development. The key factors that drive the growth of the market in this region are increase in patient population, the rise in the prevalence of Alzheimer disease, and a significant rise in research and development activities in pharmaceutical companies for the treatment of diseases such as cancer and Alzheimer.  

Asia-Pacific is expected to register the highest CAGR during the forecast period. Factors influencing the growth of this region include increasing geriatric population, rising prevalence of cataract, and increasing prevalence of Alzheimer disease in this region.

The European region is projected to register the highest CAGR during the forecast period due to increasing geriatric population included in system illness and chronic infection.

The Middle East and Africa holds the least share in the global multiplex assay market due to the presence of stringent government policies and poor economies.

Multiplex Assays Market Segmentation

Multiplex Assays Products & Services Outlook

• Consumable


• Instrument


• Software & Services

Multiplex Assays Type Outlook

• Protein multiplex assay


• Planer protein assay


• Bead-based protein assay


• Nucleic acid multiplex assay


• Planer nucleic acid assay


• Bead-based nucleic acid assay


• Other nucleic acid assay


• Cell-based multiplex assay

Multiplex Assays Technology Outlook

• Flow cytometry


• Fluorescence detection


• Luminescence


• Multiplex real-time PCR


• Other technology

Multiplex Assays Application Outlook

• Research & development


• Drug discovery & development


• Biomarker discovery & validation


• Clinical diagnostic


• Infectious disease


• Cancer


• Cardiovascular disease


• Autoimmune disease


• Nervous system disorders


• Other diseases

Multiplex Assays End-User Outlook

• Pharmaceutical and biotechnology companies


• Hospitals


• Research institutes


• Clinical laboratories


• Other end-users

Multiplex Assays Regional Outlook

• Americas


• Europe


• Asia-Pacific


• Middle East & Africa

Multiplex Assays Market Key Players

• Thermo Fisher Scientific Inc


• Illumina Inc


• Bio-Rad Laboratories Inc


• Qiagen


• Abcam plc


• BD


• Merck Sharp & Dohme Corp


• Agilent Technologies


• Meso Scale Diagnostics LLC


• Randox Laboratories Ltd


• Quanterix,


• Bio-Techne


• Seegene Inc.

Intended Audience

• Biotechnology company


• Pharmaceutical company


• Government & private laboratories


• Research & development companies


• Medical research laboratories